Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHS2300015	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2023-01-20		Betta Pharmaceuticals Co Ltd			view
CXHS2300016	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2023-01-20		Betta Pharmaceuticals Co Ltd			view
CXHL2200897	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2022-11-15		Betta Pharmaceuticals Co Ltd			view
CXHL2200896	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2022-11-15		Betta Pharmaceuticals Co Ltd			view
CXHL2300495	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2023-05-09		Betta Pharmaceuticals Co Ltd			view
CXHL2300494	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2023-05-09		Betta Pharmaceuticals Co Ltd			view
CXHS2100009	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2021-03-04	贝达药业股份有限公司	Betta Pharmaceuticals Co Ltd	In Review	2021-03-03	view
CXHS2100008	甲磺酸贝福替尼胶囊	Befotertinib Mesylate	Capsule	Chemical Drugs(1)	New Drug Application	2021-03-04	贝达药业股份有限公司	Betta Pharmaceuticals Co Ltd	In Review	2021-03-03	view